The development prospect of the hottest European p

The development prospect of European pharmaceutical packaging materials

it is estimated that the sales of pharmaceutical packaging in Europe reached US $4billion in 2002 and will reach US $5.1 billion in 2007

compared with the level in 2000, the market share of paper and paperboard will decline slightly before 2007, but this does not mean that the sales will decrease. On the contrary, it reflects the relatively faster growth of contact packaging, that is, containers or blister eye packaging

plastic accounts for 28% of the sales of pharmaceutical packaging in Europe. It is a trend for the raw materials of packaging containers, syringes and ampoules to turn from glass to plastic, but the development speed is slow

it is estimated that the European pharmaceutical industry uses 1.3 billion glass bottles every year. At $0.08 each, a pull plate can be applied to multiple types of terminal tests, and its cost will be $100million per year. Ampoules, vials, syringes and other products have become the main market of the glass industry, and account for the majority in quantity and value

all metal packaging is still an option. It provides better barrier than plastic, and provides convenience for patients to use. It can be used to pack large or fragile tablets. Although the price is relatively expensive, it can well meet the requirements of environmental protection packaging. The consumption of metal materials, especially aluminum foil as a part of blister eye packaging material, will not be reduced

self adhesive labels still account for most of the label market. This trend may continue to increase the value of the label market, but will not increase sales accordingly

the future growth of packaging machinery sales is likely to come from the most sophisticated machines, such as the cleanest, most reliable and most efficient machines

the role of the packaging industry is obvious in meeting the needs of the pharmaceutical industry. The development direction of professional pharmaceutical packaging companies is to obtain further specialization by providing more perfect services

according to the research of the British market organization on the European drug packaging market, the focus of drug packaging will change greatly in the next few years, especially the container packaging will turn to cardboard box and blister eye packaging, and the market share of bottle cap and bottle seal will also decline due to the reduction of container use. Labels and loose leaf prints will become more important

in the long run, more drugs will be sold in the form of drug delivery systems, such as nasal sprays, rather than injections. Many injectable products may also begin to be sold in the form of needle free injection. Although this cannot increase the use of containers, the additional cost will help drive the growth of its market share. At the same time, the market share of cartons is likely to decline, mainly because the market of this industry is unlikely to have greater technological progress and will not produce cartons with additional pricing

market scope

it is estimated that the total annual sales of drug packaging materials market in Europe (including Eastern Europe) reached US $3.246 billion. The main packaging forms are containers and cartons, each accounting for 1/4 of the total sales; Followed by blister eye packaging (including PVC strips and small bags), accounting for about 22%; The rest is occupied by drug delivery systems including bottle seals, labels and other categories. In terms of materials, paper and paperboard sales accounted for 37%, plastic sales accounted for 28%, metal sales accounted for 26%, and glass sales accounted for only 9%

from the future to 2007, the sales of packaging materials is expected to grow in parallel with the sales of drugs, and the negative effects of reducing the packaging weight will be balanced by the high-value packaging trend. In fact, the sales of packaging may grow faster than the sales of drugs, although the range will not be too large. This is because pharmaceutical companies are willing to buy packaging that is more expensive, safer, vandal proof, child friendly, convenient for the elderly and can protect privacy. Based on this, the sales volume of pharmaceutical packaging will reach US $4billion in 2002 and US $5.1 billion in 2007, compared with us $3.2 billion in 1998. The growth rate of 5% - 6% in the first half of this period will become 4% in the second half of the next decade

paper packaging materials

as mass packaging tends to be patient packaging (requiring independent outer packaging, labels and loose leaf prints), paper and paperboard - mainly in the form of cartons, labels and loose leaf prints - account for a higher proportion of packaging tax than other materials (37% in 1998), and may continue to increase in the next few decades. In addition, pharmaceutical companies are becoming more willing to pay extra for high-quality appearance

compared with the level in 2000, the market share of paper and paperboard will fall slightly before 2007. This slight decline does not mean a decrease in sales, but rather reflects the relatively faster growth of contact packaging, that is, containers or blister eye packaging. After 2000, the main driving force for the growth of paper or paperboard (especially the trend of packaging to patients) may no longer exist, and more interest will turn to improving the design of child misuse prevention, damage prevention and convenience for the elderly, which are mainly focused on containers and blister eye packaging rather than cartons, labels or loose leaf prints

the annual consumption of folding cartons in Europe is estimated to be 9billion, which is equivalent to a market value of 540million US dollars at US $0.06 each. In the next few decades, the use of folding cartons will increase. After this period of time, the growth of sales will be consistent with the overall market growth, except for the reduction in volume caused by the attempts of prescription drug manufacturers to reduce the package size. Some companies, such as SK Bicheng, claim that considerable savings have been achieved as a result, and other companies are bound to follow suit

smuggling and theft during transportation can cause problems for prescription drugs, and the packaging counter method is likely to be used by the company for selected products - especially new and more expensive products. These methods include the use of holographic technology to verify reliability, but popular marking technology is unlikely to appear in the next five years (or even the next 10 years), because there needs to be a unified standard before this method plays its full role

the prediction of loose leaf printing in the next few decades is to maintain the same size, and the increase of its dosage is expected to be consistent with that of drugs. The new regulations in the UK will further increase the cost of loose leaf printing and labels. In addition, there are no factors that will affect sales. Recently, there have been many new developments, especially in the United States. The appearance of loose leaf printing with labels may make the outer packaging carton of containers redundant, and there is no need to add labels to the packaging. Although this method may not develop as rapidly in Europe as in the United States, it is likely to become more popular. In the United States, container packaging is still more popular than blister eye packaging. Using labels and loose leaf prints is unlikely to reduce the number or cost of packaging, but simplifying the packaging process reduces its cost

Plastic packaging materials

Plastic accounts for 28% of the sales of European drug packaging, including containers, bottle caps, bottle seals, blister eye packaging and other packaging forms. In the medium and short term, the sales of blister eye packaging will show the fastest growth, and the replacement of bottle glass is likely to grow later

in production containers, including syringes and ampoules, it is a trend to turn from glass to plastic, but the development speed is slow. Because the ingredients filtered from plastics may pollute products, especially liquids, the administration has tried to manage plastics more carefully. Plastic is slowly replacing glass for packaging syrup. The main reason is that plastic containers often have a wide bottleneck, which makes it easier to fill. The production process on the filling line is also faster, which is not fragile and can provide a larger label area to carry more information. Only by properly pricing and improving the resistance of plastic packaging, China has independently developed medium and high-level vibration experimental machine isolation performance, the acceptance rate of users can increase

except that plastic cannot play a sufficient barrier role in some products, most bottle caps are made of plastic at present. Aluminum covers are still in use and plastic is unlikely to replace them, which is a problem. Therefore, the growth of plastic bottle caps depends on the growth of drug sales and prices, rather than expecting to replace some form of bottle caps. In the medium and long term, a bottle cap that is convenient for the elderly and can prevent children from misuse may be developed to expand the market, but at present, there is no obvious sign

plastic tubes can be used to produce vials, ampoules and suppository packages or to produce hoses for ointment. For vials and ampoules, because they can be produced by forming filling sealing operation and are not easy to be damaged, pharmaceutical companies such as armacia puqiang have introduced unbreakable plastic vials to transmit cytotoxic drugs

packaging liquid drugs with plastic will often shorten the validity period of drugs. Due to the relatively weak barrier effect of commercial plastics, there seems to be no progress in solving this problem in the past, but some new materials, such as cyclic hydrocarbon copolymers, can overcome these weaknesses. Polyethylene naphthalene has better barrier property than the polymer currently used. Recently, stability experiments have been carried out on this material, although this work is only aimed at plastic containers at present

in drug packaging, the main purpose of plastic film is to form blister eyes and cheap plastic strips. The development of new materials is making great changes in this field. For example, the cyclic hydrocarbon copolymer film shows a more transparent and better barrier effect and can reduce the weight (without the barrier formed by the current multilayer film and coating)

blister eye packaging has good adaptability and appearance, and provides effective solutions for many small and difficult to package products. The demand for heat sealing equipment with simple structure and rapid transformation is increasing, and there are many options, including robot based intelligent aluminum plastic packaging system that can meet the requirements of FDA

glass packaging materials

glass products account for 9% of annual sales. Both glass bottles and ampoules are being challenged by plastic products, but the excellent barrier and good sensory properties of glass can often make up for its fragile defects

the development trend of packaging is towards glass